In fact, if the dosing history is unknown or incomplete, a drug concentration measurement loses all predictive value
Therefore, we estimate that this proposal will result in a decrease in burden of between 36,720 hours (0.67 hours 12 months 4,590 ASCs) at a savings of $2,074,680 (36,720 hours $56.50/hour) and 41,310 hours (0.75 hours 12 months 4,590 ASCs) at a savings of $2,420,766 (41,310 hours $58.60/hour) annually across all 4,590 ASCs under OMB control number 0920-1317
Releases copper to apo-enzymes and copper-dependent transcription factors a carrier-peptide role in controlled-stoichiometry delivery
These results indicate that no specific dose adjustment for cagrilintide is required for people with renal or hepatic impairment